Optimizing selection of antithrombotic therapy in patients requiring PCI and long term anticoagulation

Area of Science:

• Cardiology
• Pharmacology
• Geriatrics

Background:

• Patients on long-term anticoagulation needing percutaneous coronary intervention (PCI) present a complex clinical challenge.
• The aging population increases the incidence of comorbidities and the need for dual therapies.
• Balancing antithrombotic and antiplatelet therapy is critical to mitigate risks.

Purpose of the Study:

• To review the current evidence on antiplatelet therapy selection for patients on long-term anticoagulation undergoing PCI.
• To provide a clinical framework for managing these high-risk patients.

Main Methods:

• Literature review of current evidence.
• Analysis of risk-benefit profiles of different antiplatelet strategies.
• Synthesis of data to inform clinical decision-making.

Main Results:

• Significant clinical equipoise exists regarding optimal antiplatelet therapy post-PCI in anticoagulated patients.
• Risk of thromboembolism and stent thrombosis must be carefully weighed against major bleeding risk.
• Current evidence suggests individualized treatment approaches are necessary.

Conclusions:

• A framework is provided to guide clinicians in selecting appropriate antiplatelet therapy.
• Personalized risk assessment is key to optimizing outcomes in this patient population.
• Further research is needed to establish definitive guidelines.